Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 4.
Article
Brown, N;
McBain, C;
Nash, S;
Hopkins, K;
Sanghera, P;
Saran, F;
Phillips, M;
... Mulholland, P; + view all
(2016)
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma.
PLoS ONE
, 11
(5)
10.1371/journal.pone.0156369.
|
|
Johnson, P;
Federico, M;
Kirkwood, A;
Fossa, A;
Berkahn, L;
Carella, A;
d'Amore, F;
... Barrington, S; + view all
(2016)
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
New England Journal of Medicine
, 374
(25)
pp. 2419-2429.
10.1056/NEJMoa1510093.
|
 |
|
Mainwaring, P.N.;
Cunningham, D.;
Gregory, W.;
Hoskin, P.;
Hancock, B.;
Norton, A.J.;
MacLennan, K.;
... Linch, D.; + view all
(2001)
Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.
Blood
, 97
(10)
pp. 2991-2997.
10.1182/blood.V97.10.2991.
|
 |
|
Townsend, W;
Johnson, RJ;
Pottinger, BT;
Counsell, N;
Smith, P;
Chadwick, H;
Evans, K;
... Rudin, CE; + view all
(2016)
A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320.
Leukemia & Lymphoma
, 57
(9)
pp. 2232-2234.
10.3109/10428194.2015.1133814.
|
